Literature DB >> 16490765

Structure of the lipid A-inner core region and biological activity of Plesiomonas shigelloides O54 (strain CNCTC 113/92) lipopolysaccharide.

Jolanta Lukasiewicz1, Tomasz Niedziela, Wojciech Jachymek, Lennart Kenne, Czeslaw Lugowski.   

Abstract

Plesiomonas shigelloides is a Gram-negative rod associated with episodes of intestinal infections and outbreaks of diarrhea in humans. The extraintestinal infections caused by this bacterium, for example, endopthalmitis, meningitidis, bacteremia, and septicemia, usually have gastrointestinal origin and serious course. The lipopolysaccharide (LPS, endotoxin) as virulence factor is important in enteropathogenicity of this bacterium. LPSs of P. shigelloides and especially their lipid A part, that is, the immunomodulatory center of LPS, have not been extensively investigated. The structure of P. shigelloides O54 lipid A was determined by chemical analysis combined with MALDI-TOF mass spectrometry, and the intact Kdo-containing core region was investigated by NMR spectroscopy on deacylated LPS. Products from alkaline deacylation of LPS, containing 4-substituted uronic acids, are usually very complex and difficult to separate. Since Kdo residues, like sialic acids, form complexes with serotonin, we used immobilized serotonin for one-step isolation of oligosaccharide containing the intact Kdo region from the reaction mixture by affinity chromatography. The major form of lipid A was built of beta-d-GlcpN4PPEtn-(1-->6)-alpha-d-GlcpN1P disaccharide substituted with 14:0(3-OH), 12:0(3-OH), 14:0(3-O-14:0), and 12:0(3-O-12:0) acyl groups at N-2, O-3, N-2', and O-3', respectively. This is a novel structure among known lipid A molecules. Analysis of intact Kdo-lipid A region, lipid A and its linkage with the core oligosaccharide completes the structural investigation of P. shigelloides O54 LPS, resolving the entire molecule. Biological activities and observed discrepancy between in vitro and in vivo activity of P. shigelloides and Escherichia coli LPS are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16490765     DOI: 10.1093/glycob/cwj094

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  7 in total

Review 1.  Plesiomonas shigelloides Revisited.

Authors:  J Michael Janda; Sharon L Abbott; Christopher J McIver
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

2.  The elucidation of the structure of the core part of the LPS from Plesiomonas shigelloides serotype O17 expressing O-polysaccharide chain identical to the Shigella sonnei O-chain.

Authors:  Joanna Kubler-Kielb; Rachel Schneerson; Chris Mocca; Evgeny Vinogradov
Journal:  Carbohydr Res       Date:  2008-09-24       Impact factor: 2.104

3.  Two Kdo-heptose regions identified in Hafnia alvei 32 lipopolysaccharide: the complete core structure and serological screening of different Hafnia O serotypes.

Authors:  Jolanta Lukasiewicz; Tomasz Niedziela; Wojciech Jachymek; Lennart Kenne; Czeslaw Lugowski
Journal:  J Bacteriol       Date:  2008-11-14       Impact factor: 3.490

4.  Structure-Activity Relationship of Plesiomonas shigelloides Lipid A to the Production of TNF-α, IL-1β, and IL-6 by Human and Murine Macrophages.

Authors:  Marta Kaszowska; Marta Wojcik; Jakub Siednienko; Czeslaw Lugowski; Jolanta Lukasiewicz
Journal:  Front Immunol       Date:  2017-12-11       Impact factor: 7.561

5.  NMR study of the O-specific polysaccharide and the core oligosaccharide from the lipopolysaccharide produced by Plesiomonas shigelloides O24:H8 (strain CNCTC 92/89).

Authors:  Lena C E Lundqvist; Marta Kaszowska; Corine Sandström
Journal:  Molecules       Date:  2015-04-01       Impact factor: 4.411

6.  Structural Studies of the Lipopolysaccharide Isolated from Plesiomonas shigelloides O22:H3 (CNCTC 90/89).

Authors:  Anna Maciejewska; Brygida Bednarczyk; Czeslaw Lugowski; Jolanta Lukasiewicz
Journal:  Int J Mol Sci       Date:  2020-09-16       Impact factor: 5.923

7.  Core oligosaccharide of Plesiomonas shigelloides PCM 2231 (Serotype O17) lipopolysaccharide--structural and serological analysis.

Authors:  Anna Maciejewska; Jolanta Lukasiewicz; Marta Kaszowska; Aleksandra Man-Kupisinska; Wojciech Jachymek; Czeslaw Lugowski
Journal:  Mar Drugs       Date:  2013-02-06       Impact factor: 5.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.